enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Esketamine - Wikipedia

    en.wikipedia.org/wiki/Esketamine

    Esketamine is the second drug to be approved for treatment-resistant depression by the FDA, following olanzapine/fluoxetine (Symbyax) in 2009. [ 25 ] [ 50 ] Other agents, like the atypical antipsychotics aripiprazole (Abilify) and quetiapine (Seroquel), have been approved for use in the adjunctive therapy of major depressive disorder in people ...

  3. Sofosbuvir/velpatasvir - Wikipedia

    en.wikipedia.org/wiki/Sofosbuvir/velpatasvir

    Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [2] [5] [6] [7] It combines sofosbuvir and velpatasvir. [2] [5] [6] It is more than 90% effective for hepatitis C genotypes one through six. [2]

  4. Velpatasvir - Wikipedia

    en.wikipedia.org/wiki/Velpatasvir

    Velpatasvir reaches highest blood plasma levels three hours after oral intake together with sofosbuvir. Plasma protein binding is over 99.5%. It is slowly metabolised by the liver enzymes CYP2B6, CYP2C8 and CYP3A4.

  5. Does Medicare Cover Ketamine Infusions? - AOL

    www.aol.com/does-medicare-cover-ketamine...

    Although the FDA has approved ketamine for use as an anesthetic, infusion therapy hasn't been approved to treat chronic pain, depression, or other conditions. Skip to main content. Subscriptions ...

  6. XW10508 - Wikipedia

    en.wikipedia.org/wiki/XW10508

    XW10508 is an orally active prodrug of esketamine, an NMDA receptor antagonist, which is under development for the treatment of major depressive disorder and chronic pain. [1] [4] [2] [3] It is taken by mouth. [1] [2] [3] The drug is a novel esketamine analogue and conjugate that acts as a prodrug of esketamine. [3]

  7. Ketamine in society and culture - Wikipedia

    en.wikipedia.org/wiki/Ketamine_in_society_and...

    After the publication of the NIH-run antidepressant clinical trial, clinics began opening in which the intravenous ketamine is given for depression. [5] [6] This practice is an off label use of IV ketamine in the United States, though the intranasal version of esketamine has been approved by the FDA for treatment of depression [5] [7] In 2015 there were about 60 such clinics in the US; the ...

  8. List of investigational hallucinogens and entactogens - Wikipedia

    en.wikipedia.org/wiki/List_of_investigational...

    This is a list of investigational hallucinogens and entactogens, or hallucinogens and entactogens that are currently under formal development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.

  9. Sofosbuvir - Wikipedia

    en.wikipedia.org/wiki/Sofosbuvir

    Following its approval by the FDA in 2013, [34] the price of sofosbuvir as quoted in various media sources in 2014 ranged from $84,000 to $168,000 depending on course of treatment in the U.S. [39] and £35,000 in the United Kingdom for a 12-week regimine, [40] causing considerable controversy.